Nectar Lifescience Ltd
₹13.34
(-1.33)%
Sun, 01 Feb 2026, 05:34 pm
Health Technology
Pharmaceuticals: Major
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
260.70
Net Profit
-113.68
P/B
0.54
Sector P/E
32.01
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.22
Interest Cover (Industry)
10.71
ROCE (Industry)
11.89
RONW (Industry)
11.62
ROE
-11.23
ROCE
-5.33
Debt/Equity
0.60
EPS (TTM)
0
Dividend Yield
0
Book Value
36.75
Interest Cover
-1.17
Analysis
all
- Nectar Lifesciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Nectar Lifesciences is profitable, therefore cash runway is not a concern.
- Nectar Lifesciences is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (33.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2.2x debt.
- Nectar Lifesciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Nectar Lifesciences's dividends as it is not paying a notable one for India.
- Nectar Lifesciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Nectar Lifesciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Nectar Lifesciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 44.91 | 44.91 | 44.53 | 44.53 | 44.53 |
| FII | 0.52 | 0.62 | 0.81 | 1.65 | 0.73 |
| DII | 5.82 | 0.09 | 0.19 | 0.16 | 0 |
| Public | 48.73 | 54.37 | 54.44 | 53.65 | 54.72 |
| Government | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 31.17 | 23.53 | 18.53 | 15.89 | 10.89 | 8.25 | 0.61 |
| Fibonacci | 23.53 | 20.61 | 18.81 | 15.89 | 12.97 | 11.17 | 8.25 |
| Camarilla | 15.62 | 14.92 | 14.22 | 15.89 | 12.82 | 12.12 | 11.42 |
Pivots Level: Classic
R3
+15.28
31.17
R2
+7.64
23.53
R1
+2.63
18.53
S1
-5.01
10.89
S2
-7.64
8.25
S3
-15.28
0.61
Moving Average
Period
Value
10-EMA
14.29
20-EMA
15.52
30-EMA
16.23
50-EMA
16.70
100-EMA
17.14
200-EMA
19.34
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 23 Jan 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 03 Dec 2025 | buyback | ||
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 26 Aug 2025 | agm | ||
| 07 Jul 2025 | egm | ||
| 19 Aug 2024 | agm | ||
| 26 May 2023 | agm | ||
| 30 May 2022 | agm | ||
| 23 Jul 2021 | agm | ||
| 04 Jan 2021 | egm |
Peer Comparison
Nectar Lifescience Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Divis Laboratories Ltd
About Nectar Lifescience Ltd
Nectar Lifescience is engaged in promoting education and employment enhancing vocational skills among women to help them in earning their livelihood.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1995
Headquarters
CEO
Sanjiv Goyal
Employees
Contact
Website
http://www.neclife.com
cs@neclife.com
Phone
91-1762-308000
Location
Village Saidpura, Tehsil Derabassi S A S Nagar, Mohali, Punjab, 140507
nectar lifescience ltd History
| Year | History |
|---|---|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2019 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| JAIDEEP SAMPAT | Sell | 1695746 | 20.54 | 04 Dec 2025 |
| ANKITA VISHAL SHAH | Sell | 1349525 | 20.65 | 04 Dec 2025 |
| IRAGE BROKING SERVICES LLP | Sell | 1479033 | 20.47 | 04 Dec 2025 |
| MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED | Buy | 1500000 | 20.93 | 04 Dec 2025 |
| QE SECURITIES LLP | Buy | 1180239 | 20.6 | 04 Dec 2025 |
| RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED | Buy | 1500000 | 20.87 | 04 Dec 2025 |
| ANKITA VISHAL SHAH | Buy | 1349525 | 21.01 | 04 Dec 2025 |
| QE SECURITIES LLP | Sell | 1266933 | 20.36 | 04 Dec 2025 |
| IRAGE BROKING SERVICES LLP | Buy | 800112 | 20.48 | 04 Dec 2025 |
| L7 HITECH PRIVATE LIMITED | Buy | 85100 | 20 | 11 Jul 2025 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800